HUGE News and Press, FSD Pharma Inc. From 05/11/22

FSD Pharma (NASDAQ: HUGE) (CSE: HUGE) (FSE: 0K9A) , a life sciences holding company dedicated to building a portfolio of assets and biotech solutions, has closed the sale of non-core assets for $16.4 million. This news and additional information about the company was featured in an Investme...

VANCOUVER, British Columbia, May 11, 2022 (GLOBE NEWSWIRE) -- FSD Pharma Inc. (NASDAQ:HUGE) (CSE:HUGE) (FSE:0K9A), a life sciences holding company dedicated to building a portfolio of assets and biotech solutions, has closed the sale of non-core assets for $16.4 million. A Media Sni...

FSD Pharma (NASDAQ: HUGE) (CSE: HUGE) (FRA: 0K9A) ,a life sciences holding company dedicated to building a portfolio of assets and biotech solutions, today announced the closing of the sale of the company’s former cannabis processing facility located in Cobourg, Ontario, Canada, for ...

FSD Pharma (NASDAQ:HUGE) said it closed the sale of its cannabis processing facility in Cobourg, Ontario for gross proceeds of C$16.4M in cash. The company said the sale, which completed on May 6, included a 26.1-hectacre parcel of land and 50.8K square-meter building, which FSD acq...

Nets CAD$15,480,780 cash in non-dilutive capital Current cash position of approximately CAD$50 million or approximately CAD $1.30 per share with only 38.4 million shares issued Profit realized on the sale of the non-core asset which was acquired by FSD Pharma in 2017 for CAD$5...

FSD Pharma Inc. (NASDAQ: HUGE) (CSE: HUGE) (FRA: 0K9) (“ FSD Pharma ” or the “ Company ”), a life sciences holding company dedicated to building a portfolio of assets and biotech solutions, announced today that the Company was successful in its motion...

FSD Pharma (NASDAQ: HUGE) (CSE: HUGE) (FRA: 0K9A) , a life-sciences holding company dedicated to building a portfolio of assets and biotech solutions, has entered into an agreement with Tekkfund Capital Corp. According to the contract, Tekkfund will help structure and assist with FSD Pharma...

FSD Pharma (NASDAQ:HUGE) said that on April 15 it signed a contract with Tekkfund Capital (TCC) for services to structure and assist with certain business development strategies. Under the agreement, the company said it will pay TCC a monthly fee of C$12.5K plus HST; and issue, on a monthly b...

FSD Pharma Inc. (NASDAQ: HUGE) (CSE: HUGE) (FRE: 0K9A) (“ FSD Pharma ” or the “ Company ”), a life sciences holding company dedicated to building a portfolio of assets and biotech solutions, announced today that on April 15 th , 2022, the Company ...

FSD Pharma (NASDAQ: HUGE) (CSE: HUGE) (FRA: 0K9A) ,a life sciences holding company dedicated to building a portfolio of assets and biotech solutions, today announced the appointment of David Allan and John McGraw, PhD, MSc, to the company’s advisory board. Allan is the 2017 recipient...